In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo
YZ: Writing original draft, Supervision, Data curation, Formal analysis
SIDE EFFECTS & RISKS GHK-Cu has a very favorable safety profile, which is expected given that it is a naturally occurring molecule your body already produces
It is also a great antioxidant that works well by itself as well as in combination with certain other skin lightening ingredients
Find out which format may fit your lifestyle and how to get started
Suh WS, Kim YS, Schimmer AD, Kitada S, Minden M, Andreeff M , Suh N, Sporn M, Reed JC